Announcements
Sidley Represents Placement Agent in PIPE Investment in Ispire Technology
June 28, 2023
Sidley represented US Tiger Securities, Inc. (US Tiger), as the exclusive placement agent in the private placement of a total of 1,117,420 shares of common stock of Ispire Technology Inc. (Ispire) (NASDAQ: ISPR), raising gross proceeds of approximately US$8 million. The transaction was completed on June 26, 2023. Ispire intends to use the funds to support its long term growth strategy, including the development of manufacturing operations in Vietnam and California, research and development activities, and marketing and promotion.
Los Angeles, California-based Ispire Technology is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and other vaping products.
The Sidley team was led by partners Meng Ding and David Kalani Lee and included senior managing associate Liming Xu and senior legal assistant Alice Liu. Partner David M. Katz and counsel Benjamin L. Nager (both based in New York) advised on FINRA-related issues.
In April 2023, the Sidley team also advised US Tiger as the lead underwriter in the Nasdaq IPO of Ispire.
Los Angeles, California-based Ispire Technology is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and other vaping products.
The Sidley team was led by partners Meng Ding and David Kalani Lee and included senior managing associate Liming Xu and senior legal assistant Alice Liu. Partner David M. Katz and counsel Benjamin L. Nager (both based in New York) advised on FINRA-related issues.
In April 2023, the Sidley team also advised US Tiger as the lead underwriter in the Nasdaq IPO of Ispire.
Contacts
Capabilities
Suggested News & Insights
Sidley Advises UpEnergy on World Bank Clean Cooking Outcome BondDecember 18, 2025Sidley Advises Wealthfront in Initial Public OfferingDecember 17, 2025Sidley Advises Brookfield India Real Estate Trust on Its US$390 Million QIPDecember 16, 2025U.S. Legislation Subjects Directors and Officers of Foreign Private Issuers to Section 16(a) Reporting ObligationsDecember 15, 2025Sidley Represents Immunovant in US$550 Million OfferingDecember 12, 2025Sidley Ranked in Chambers Asia-Pacific 2026December 11, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory